 |
|
|
| |
THE AGILE 3+ AND 4 SCORES MOST ACCURATELY PREDICT MAJOR ADVERSE LIVER OUTCOMES AND DEATH COMPARED TO LIVER STIFFNESS MEASUREMENT AND FIBROSCAN- AST SCORE
|
| |
| |
AASLD 2022 Nov 4-8
Emily Truong, Internal Medicine, Cedars- Sinai Medical Center, Jeffrey Gornbein, UCLA, Ju Dong Yang, Karsh Division of Gastroenterology and Hepatology, Cedars Sinai Medical Center; Comprehensive Transplant Center, Cedars Sinai Medical Center, Stephen A. Harrison, Radcliffe Department of Medicine, University of Oxford, Naim Alkhouri, Arizona Liver Health and Mazen Noureddin, Houston Methodist Hospital
|
| |
|
|
|
|
|
